-

STEMCELL Technologies Expands into Toronto’s MaRS Centre, Grows North American Presence

TORONTO--(BUSINESS WIRE)--STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the opening of its new Canadian sales office at the MaRS Centre in downtown Toronto, Ontario.

“The opening of our new Toronto base marks a major milestone in STEMCELL’s 30-year history and is a testament to our growing presence in North America,” said Dr. Allen Eaves, President and CEO, STEMCELL. “This facility will enable us to strengthen ties in the Toronto area and better support the scientists in both academia and industry who are doing great work here.”

Located in the city’s Discovery District, the MaRS Centre is North America’s largest urban innovation hub. Consisting of over 1.5 million square feet, it hosts a curated roster of more than 120 tenants, including globally recognized research labs, tech corporates, capital providers, and many of Canada’s most promising health and life sciences startups. STEMCELL will take up occupancy at MaRS' West Tower, a LEED Gold building, at 661 University Avenue.

“As a company of Scientist Helping Scientists, STEMCELL is looking forward to being part of the MaRS community and collaborating with leading principal investigators to tackle some of the biggest challenges of our time,” said Dr. Eaves.

Headquartered in Vancouver, British Columbia, STEMCELL has a global presence, with offices in eight countries: Canada, United States, United Kingdom, France, Germany, China, South Korea, and Singapore. In total, STEMCELL has sales staff in 20 countries and distributors in 80 other countries. Of its 2400 global employees, 1800 are based in Canada.

STEMCELL’s connection with MaRS began when the company commissioned bronze portraits of Drs. James Till and Ernest McCulloch—considered the pioneers of stem cell research—by artist Ruth Abernethy. Unveiled in 2017, the sculpture was donated to MaRS by STEMCELL and today sits outside the MaRS Centre entrance. A sister sculpture can be found in front of Vancouver’s Science World near STEMCELL’s head office.

“As a PhD student, I was honored to study under Drs. Till and McCulloch, and so the opening of this office at MaRS close to the University of Toronto is especially meaningful for me,” said Dr. Eaves. “This is where it all began for stem cell research and where, in large part thanks to Drs. Till and McCulloch, my own career in this area of science started. It is important to me that STEMCELL continues to build on their legacy and make big contributions to the science, biotech, and innovation ecosystem here in Toronto and beyond.”

More information about the MaRS Centre can be found by visiting https://www.marsdd.com.

About STEMCELL Technologies

STEMCELL Technologies supports life sciences research with more than 2500 specialized reagents, tools, and services. STEMCELL offers high-quality cell culture media, cell separation technologies, instruments, accessory products, educational resources, and contract assay services that are used by scientists performing stem cell, immunology, cancer, regenerative medicine, and cellular therapy research globally.

Contacts

For more information and to arrange an interview, contact:
Ryan-Sang Lee
Senior Manager, Corporate Communications, STEMCELL Technologies
public.relations@stemcell.com

STEMCELL Technologies



Contacts

For more information and to arrange an interview, contact:
Ryan-Sang Lee
Senior Manager, Corporate Communications, STEMCELL Technologies
public.relations@stemcell.com

Social Media Profiles
More News From STEMCELL Technologies

STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries

VANCOUVER, British Columbia--(BUSINESS WIRE)--To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet this man...

STEMCELL Technologies Announces Acquisition of Cellular Highways

VANCOUVER, British Columbia & CAMBRIDGE, England--(BUSINESS WIRE)--STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Cellular Highways Ltd from TTP Group Ltd. Cellular Highways is a biotechnology company based near Cambridge, United Kingdom, that specializes in advanced cell sorting technologies with applications in cell and gene therapy, drug discovery, and general cell research, especially where cells are fragile. The acquisition includes...

STEMCELL Launches Novel Cell-Engineering CellPore™ Transfection System

VANCOUVER, British Columbia--(BUSINESS WIRE)--STEMCELL Technologies has commercially launched the CellPore™ Transfection System, providing a groundbreaking new technology with the potential to advance cell engineering research and the development of novel cell therapies to cure diseases. The CellPore™ Transfection System represents a substantial leap forward for cell engineering researchers, offering a novel method—known as mechanoporation—for cargo delivery into mammalian cells. Unlike traditi...
Back to Newsroom